These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32802404)

  • 21. Plant MicroRNA Potential in Targeting Sars-CoV-2 Genome Offering Efficient Antiviral MiRNA-Based Therapies.
    Hajieghrari B; Rahmanian-Koshkaki S
    Microrna; 2022; 11(3):245-262. PubMed ID: 35984027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle.
    Lin CW; Lo CW; Tsai CN; Pan TC; Chen PY; Yu MJ
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29315273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with negative conversion of viral RNA in hospitalized children infected with SARS-CoV-2 Omicron variant in Shanghai, China: a retrospective analysis.
    Yang Y; You Y; Liu Y; Geng L; Huang L; Zhou H; Piao X; Liu X; Wu M; Wang Y; Zhou L; Wang P; Shen S; Hu M; Han Z; Xue Z
    BMC Infect Dis; 2023 Apr; 23(1):264. PubMed ID: 37101288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients.
    Wang Y; Zhu X; Jiang XM; Guo J; Fu Z; Zhou Z; Yang P; Guo H; Guo X; Liang G; Zeng P; Xiao G; Ma J; Yin X; Zhang LK; Yan C; Zhang CY
    Signal Transduct Target Ther; 2021 Aug; 6(1):300. PubMed ID: 34381015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity.
    Labach DS; Kohio HP; Tse EA; Paparisto E; Friesen NJ; Pankovich J; Bazett M; Barr SD
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Losartan Inhibits SARS-CoV-2 Replication in Vitro.
    Nejat R; Sadr AS; Freitas B; Crabttree J; Pegan SD; Tripp RA; Najafi D
    J Pharm Pharm Sci; 2021; 24():390-399. PubMed ID: 34319871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo.
    Li M; Wang Y; Jin J; Dou J; Guo Q; Ke X; Zhou C; Guo M
    Virol Sin; 2021 Jun; 36(3):490-500. PubMed ID: 33044658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conserved MicroRNAs in Human Nasopharynx Tissue Samples from Swabs Are Differentially Expressed in Response to SARS-CoV-2.
    Eichmeier A; Kiss T; Kocanova M; Hakalova E; Spetik M; Cechova J; Tichy B
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Value of Early Positive Nucleic Acid Test and Negative Conversion Time of SARS-CoV-2 RNA in the Clinical Outcome of COVID-19 Patients.
    Zang X; Xiong L; Zhu J; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
    Front Med (Lausanne); 2022; 9():826900. PubMed ID: 35572983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Human miRNA Biomarkers Targeting the SARS-CoV-2 Genome.
    Saha I; Ghosh N; Plewczynski D
    ACS Omega; 2022 Dec; 7(50):46411-46420. PubMed ID: 36570256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.
    Yang CY; Chen YH; Liu PJ; Hu WC; Lu KC; Tsai KW
    Int J Med Sci; 2022; 19(8):1340-1356. PubMed ID: 35928726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators.
    Dias SSG; Soares VC; Ferreira AC; Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Teixeira L; Nunes da Silva MA; Barreto E; Mattos M; de Freitas CS; Azevedo-Quintanilha IG; Manso PPA; Miranda MD; Siqueira MM; Hottz ED; Pão CRR; Bou-Habib DC; Barreto-Vieira DF; Bozza FA; Souza TML; Bozza PT
    PLoS Pathog; 2020 Dec; 16(12):e1009127. PubMed ID: 33326472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berry derived constituents in suppressing viral infection: Potential avenues for viral pandemic management.
    Shahagadkar P; Shah H; Palani A; Munirathinam G
    Clin Nutr ESPEN; 2021 Dec; 46():14-20. PubMed ID: 34857187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response.
    Wu J; Liu X; Shao J; Zhang Y; Lu R; Xue H; Xu Y; Wang L; Zhou H; Yu L; Yue M; Dong C
    Virol J; 2021 Dec; 18(1):244. PubMed ID: 34876159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complete nucleotide sequence and genome organization of a novel carmovirus--honeysuckle ringspot virus isolated from honeysuckle.
    Gulati-Sakhuja A; Rains L; Tian T; Liu HY
    Arch Virol; 2011 Sep; 156(9):1635-40. PubMed ID: 21562880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celastrol: A lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion.
    Fuzo CA; Martins RB; Fraga-Silva TFC; Amstalden MK; Canassa De Leo T; Souza JP; Lima TM; Faccioli LH; Okamoto DN; Juliano MA; França SC; Juliano L; Bonato VLD; Arruda E; Dias-Baruffi M
    Drug Dev Res; 2022 Nov; 83(7):1623-1640. PubMed ID: 35989498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation.
    Souza TML; Pinho VD; Setim CF; Sacramento CQ; Marcon R; Fintelman-Rodrigues N; Chaves OA; Heller M; Temerozo JR; Ferreira AC; Mattos M; Momo PB; Dias SSG; Gesto JSM; Pereira-Dutra F; Viola JPB; Queiroz-Junior CM; Guimarães LC; Chaves IM; Guimarães PPG; Costa VV; Teixeira MM; Bou-Habib DC; Bozza PT; Aguillón AR; Siqueira-Junior J; Macedo-Junior S; Andrade EL; Fadanni GP; Tolouei SEL; Potrich FB; Santos AA; Marques NF; Calixto JB; Rabi JA
    Nat Commun; 2023 Jan; 14(1):199. PubMed ID: 36639383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Du XQ; Shi LP; Cao WF; Chen ZW; Zuo B; Hu JY
    Front Pharmacol; 2021; 12():708636. PubMed ID: 34603023
    [No Abstract]   [Full Text] [Related]  

  • 39. Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies.
    Ho HT; Peischard S; Strutz-Seebohm N; Klingel K; Seebohm G
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
    Bhavya ; Pathak E; Mishra R
    J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.